Evaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions | Zendy

Deepika Jain | Zendy; Sumiti Gupta | Zendy; Nisha Marwah | Zendy; Rajnish Kalra | Zendy; Veena Gupta | Zendy; Meenu Gill | Zendy; Nikita Jain | Zendy; Shubha Lal | Zendy; Rajeev Sen | Zendy

Open Access

Evaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions

Author(s) -

Deepika Jain,

Sumiti Gupta,

Nisha Marwah,

Rajnish Kalra,

Veena Gupta,

Meenu Gill,

Nikita Jain,

Shubha Lal,

Rajeev Sen

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.206239

Subject(s) - medicine , prostate cancer , prostate , cytokeratin , pathology , immunohistochemistry , lesion , cancer

In recent years basal cell markers (high molecular weight cytokeratin [HMWCK]) and prostate biomarker alpha-methyl acyl-coenzyme A racemase (AMACR) have been used as adjuvant to morphology in diagnostically challenging cases with a very high sensitivity and specificity. This has increased the diagnostic accuracy of prostate cancer worldwide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research